State Street SPDR S&P Biotech ETF XBI
155.06 USD -1.84 (-1.17%)
At closeNov 11, 2026, 4:01 AM EST
156.02 +0.96 +0.62%
Pre-market · Nov 11, 4:01 AM ET
153.22 Day range 157.85
109.53 52-week range 169.89
- YTD
- +27.17%
- 1 year
- +40.85%
- Market cap
- 8.20B
- YTD return
- +27.17%
- 1-year return
- +40.85%
- Volume
- 6.99M
- Avg volume
- 9.07M
- Open
- 155.22
- Previous close
- 156.90
- Day's range
- 153.22 – 157.85
- 52-week range
- 109.53 – 169.89
5D -2.30 (-1.46%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 155.11
- 200-day average
- 142.45
Next earnings
Consensus EPS estimate 0.00.
About State Street SPDR S&P Biotech ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
News
Your note
Sign in to keep a note on XBI — it syncs with the Stock Master app.